QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.073536v1 312/1/290    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Slattery, D. A. Articles by Cryan, J. F. Search for Related Content PubMed PubMed Citation Articles by Slattery, D. A. Articles by Cryan, J. F. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYCLOPENTANE DESIPRAMINE FLUOXETINE

BEHAVIORAL PHARMACOLOGY

GABA_B Receptor Antagonist-Mediated Antidepressant-Like Behavior Is Serotonin-Dependent

Neuroscience Research, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland

There is an emerging body of data purporting a role of -aminobutyric acid (GABA) in the pathophysiology of mood disorders. However, the role of metabotropic GABA_B receptors in depression is not well defined. The modified forced swim test has recently emerged as an excellent tool to assess behaviorally the role of monoamines in antidepressant action. To assess the role of GABA_B receptors in antidepressant-related behavior, we examined a number of selective GABA_B receptor ligands (novel positive modulators and antagonists) on behavior in the modified forced swim test. We demonstrate that the selective GABA_B receptor antagonists CGP56433A [[3-{1-(S)-[{3-cyclohexylmethyl)hydroxy phosphinyl}-2-(S) hydroxy propyl]amino}ethyl]benzoic acid; 1-10 mg/kg] and [3-[[1-(S)-3-dichlorophenyl)ethyl]amino]-2-(S)-hydroxy-propyl]phenylmethyl-phosphinic acid hydrochloride; 3-10 mg/kg] had a similar profile to the selective serotonin reuptake inhibitor fluoxetine; they decreased immobility and increased swimming behavior. The tricyclic antidepressant desipramine decreased immobility but increased climbing behavior. In contrast, the novel GABA_B receptor-positive modulator GS39783 (10-40 mg/kg) did not display antidepressant-like activity in the modified forced swim test. To further assess the possible interaction between GABA_B receptor antagonism and serotonin, rats were pretreated with the tryptophan hydroxylase inhibitor para-chlorophenylalanine. 5-Hydroxytryptamine depletion (>90%) abolished the antidepressant-like behavior of CGP56433A (10 mg/kg) by attenuating the increase in swimming. Together, these data demonstrate that GABA_B receptor antagonists via an interaction with the serotonergic system display antidepressant-like properties and therefore represent a novel approach for the treatment of depression.

Address correspondence to: Dr. John F. Cryan, Psychiatry Program, Neuroscience Research, Novartis Institutes for BioMedical Research WSJ 386.344, Novartis, Basel, CH-4002, Switzerland. E-mail: john_f.cryan{at}pharma.novartis.com

This article has been cited by other articles:

				Y. Temel, L. J. Boothman, A. Blokland, P. J. Magill, H. W. M. Steinbusch, V. Visser-Vandewalle, and T. Sharp Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus PNAS, October 23, 2007; 104(43): 17087 - 17092. [Abstract] [Full Text] [PDF]

				L. N. Cornelisse, J. E. Van der Harst, J. C. Lodder, P.J.J. Baarendse, A. J. Timmerman, H. D. Mansvelder, B. M. Spruijt, and A. B. Brussaard Reduced 5-HT1A- and GABAB Receptor Function in Dorsal Raphe Neurons Upon Chronic Fluoxetine Treatment of Socially Stressed Rats J Neurophysiol, July 1, 2007; 98(1): 196 - 204. [Abstract] [Full Text] [PDF]

				S. Balasubramanian, S. R. Fam, and R. A. Hall GABAB Receptor Association with the PDZ Scaffold Mupp1 Alters Receptor Stability and Function J. Biol. Chem., February 9, 2007; 282(6): 4162 - 4171. [Abstract] [Full Text] [PDF]